REVIEW A centrally acting reversible acetylcholinesterase inhibitor. The main therapeutic use is in the palliative treatment of mild to moderate Alzheimer's disease.
Myhrer T, Enger S, Aas P (2010). Behavioral side effects in rats treated with acetylcholinesterase inhibitors suggested used as prophylactics against nerve agents. Pharmacol Biochem Behav. 95(3):338-43. PMID 20184916.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. CATEGORIES APIs and Bioactives > AChR Agonists, Alzheimer's